{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:31:37Z","timestamp":1772029897117,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY20889"],"award-info":[{"award-number":["EY20889"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY003790"],"award-info":[{"award-number":["P30EY003790"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jtos.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T18:27:30Z","timestamp":1662402450000},"page":"184-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Therapeutic efficacy of topical blockade of substance P in experimental allergic red eye"],"prefix":"10.1016","volume":"26","author":[{"given":"Shudan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunpeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5732-5100","authenticated-orcid":false,"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2022.08.008_bib1","doi-asserted-by":"crossref","DOI":"10.1046\/j.1398-9995.2003.00326.x","article-title":"Animal models of allergic and inflammatory conjunctivitis","author":"Groneberg","year":"2003","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib2","article-title":"Ocular emergencies: red eye","author":"Tarff","year":"2017","journal-title":"Med Clin"},{"key":"10.1016\/j.jtos.2022.08.008_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pop.2015.05.002","article-title":"Approach to red eye for primary care practitioners","author":"Dunlop","year":"2015","journal-title":"Prim Care Clin Off Pract"},{"key":"10.1016\/j.jtos.2022.08.008_bib4","doi-asserted-by":"crossref","DOI":"10.5811\/westjem.2016.12.31798","article-title":"Differentiating urgent and emergent causes of acute red eye for the emergency physician","author":"Gilani","year":"2017","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.jtos.2022.08.008_bib5","article-title":"Diagnosis and management of red eye in primary care","author":"Cronau","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jtos.2022.08.008_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtos.2021.05.004","article-title":"Ocular redness \u2013 II: progress in development of therapeutics for the management of conjunctival hyperemia","author":"Singh","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.008_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/OPX.0000000000001182","article-title":"Brimonidine ophthalmic solution 0.025% for reduction of ocular redness: a randomized clinical trial","author":"McLaurin","year":"2018","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jtos.2022.08.008_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cxo.12846","article-title":"Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials","author":"Ackerman","year":"2019","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.jtos.2022.08.008_bib9","article-title":"Neurobiology of substance P and the NK1 receptor","author":"Mantyh","year":"2002","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/j.jtos.2022.08.008_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.10234","article-title":"Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P","author":"Goode","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jtos.2022.08.008_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-5155(01)00507-X","article-title":"Endogenous substance P in corneal epithelial cells and keratocytes","author":"Watanabe","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.008_bib12","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1601751","article-title":"Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis","author":"Suvas","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib13","doi-asserted-by":"crossref","DOI":"10.1165\/ajrcmb.24.2.4264","article-title":"Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats","author":"King","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jtos.2022.08.008_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2003.09.039","article-title":"Tachykinins and tachykinin receptors: a growing family","author":"Pennefather","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jtos.2022.08.008_bib15","article-title":"Neurogenic inflammation: the participant in migraine and recent advancements in translational Research","author":"Spekker","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtos.2022.08.008_bib16","doi-asserted-by":"crossref","DOI":"10.1515\/med-2017-0034","article-title":"Model for studying anti- allergic drugs for allergic conjunctivitis in animals","author":"Nakazawa","year":"2017","journal-title":"Open Med"},{"key":"10.1016\/j.jtos.2022.08.008_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(25)08946-1","article-title":"Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor","author":"Cascieri","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jtos.2022.08.008_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/molecules15096598","article-title":"Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury","author":"Thornton","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.jtos.2022.08.008_bib19","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.13-12217","article-title":"The ocular redness index: a novel automated method for measuring ocular injection","author":"Amparo","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2022.08.008_bib20","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.6.4.13","article-title":"Evaluating changes in ocular redness using a novel automated method","author":"Amparo","year":"2017","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.jtos.2022.08.008_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0453-y","article-title":"Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis","author":"Martinez","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jtos.2022.08.008_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.1995.tb16329.x","article-title":"Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the Guinea\u2010pig conjunctiva","author":"Figini","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtos.2022.08.008_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2019.09.020","article-title":"Neurokinin-1 receptor antagonism ameliorates dry eye disease by inhibiting antigen-presenting cell maturation and T helper 17 cell activation","author":"Yu","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2022.08.008_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/s13223-020-0403-9","article-title":"A contemporary look at allergic conjunctivitis","author":"Dupuis","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e3181a18acd","article-title":"Image analyses of the kinetic changes of conjunctival hyperemia in histamine-induced conjunctivitis in Guinea pigs","author":"Fukushima","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.008_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1098-2299(199902)46:2<163::AID-DDR10>3.0.CO;2-O","article-title":"The RBI handbook of receptor classification and signal transduction","author":"Williams","year":"1999","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.jtos.2022.08.008_bib27","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00031.2013","article-title":"Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease","author":"Steinhoff","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jtos.2022.08.008_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2020.05.011","article-title":"Restoration of regulatory T-cell function in dry eye disease by antagonizing substance P\/Neurokinin-1 receptor","author":"Taketani","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2022.08.008_bib29","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.165.1.182","article-title":"IL-4 and IFN-\u03b3 up-regulate substance P receptor expression in murine peritoneal macrophages","author":"Marriott","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib30","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.11.5654","article-title":"Human monocytes and macrophages express substance P and neurokinin-1 receptor","author":"Ho","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#","article-title":"Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation","author":"Lambrecht","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib32","doi-asserted-by":"crossref","DOI":"10.2174\/1389450116666151019100216","article-title":"Substance P and its inhibition in ocular inflammation","author":"Bignami","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jtos.2022.08.008_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/S0165-5728(00)00466-5","article-title":"Expression of authentic substance P receptors in murine and human dendritic cells","author":"Marriott","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.01.012","article-title":"A mast-cell-specific receptor mediates neurogenic inflammation and pain","author":"Green","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jtos.2022.08.008_bib35","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.174.7.3906","article-title":"IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation","author":"Arsenescu","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2222.2005.02264.x","article-title":"Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways","author":"Dinh","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jtos.2022.08.008_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2222.1997.tb00721.x","article-title":"Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis","author":"Fujishima","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jtos.2022.08.008_bib38","doi-asserted-by":"crossref","DOI":"10.1159\/000234229","article-title":"Substance P and calcitonin gene-related peptide: effects on mast cells and in human skin","author":"Foreman","year":"1987","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jtos.2022.08.008_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/1523-1747.ep12470339","article-title":"Substance P-induced histamine release in human cutaneous mast cells","author":"Ebertz","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtos.2022.08.008_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2019.01.002","article-title":"Substance P-mediated cardiac mast cell activation: an in vitro study","author":"Levick","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.jtos.2022.08.008_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtos.2021.05.003","article-title":"Ocular redness \u2013 I: etiology, pathogenesis, and assessment of conjunctival hyperemia","author":"Singh","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.008_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2016.00296","article-title":"The therapeutic potential of targeting substance P\/NK-1R interactions in inflammatory CNS disorders","author":"Johnson","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jtos.2022.08.008_bib43","doi-asserted-by":"crossref","DOI":"10.1248\/bpb.26.1696","article-title":"Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of Guinea pigs","author":"Fukushima","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jtos.2022.08.008_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2003.10.013","article-title":"A chronic model for evaluating the itching associated with allergic conjunctivitis in rats","author":"Minami","year":"2004","journal-title":"Int Immunopharm"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:27Z","timestamp":1761540567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012422000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"alternative-id":["S1542012422000805"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of topical blockade of substance P in experimental allergic red eye","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}